跳至主要内容
临床试验/CTRI/2023/06/053524
CTRI/2023/06/053524尚未招募3 期

Evaluation of the efficacy of shatapushpa taila nasya in the management of artava kshaya

DR ANUDEEPA NATH1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年6月25日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Decrease In Symptoms Of Artava Kshaya Like

研究概览

简要总结

THIS IS AN EFFECTIVENESS OF SHATAPUSHPA TAILA IN THE FORM OF NASYA IN THE MANAGEMENT OF ARTAVA KSHAYA . THIS IS DONE COMPULSORY PART OF POST GRADUATE COURSE. TOTAL NUMBER OF PATIENTS TO BE STUDIED IS 30 WITH DURATION OF 30 DAYS.

研究设计

研究类型
Interventional
分配方式
Adaptive randomization, such as minimization
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • Infrequent Menses At Interval Between Two Cycle Exceeding More Than 35 Days
  • Reduced Quantity Of Flow That Is Using Less Than 2 Pads Per Day 3.Artava Kshaya Due To PCOD 4.Duration Of Flow Less Than Two Days 5.Irrespective Of Marriage.

排除标准

  • Pregnant Women Lactating Women Patient Having Systemic Disorders Hyperthyroidism Severe Anaemia hb level Less Than 7Gm/Dl Any Type Of Malignancy.

结局指标

主要结局

Decrease In Symptoms Of Artava Kshaya Like

时间窗: 3 months

To Normalise The Duration Of Bleeding

时间窗: 3 months

Normalise The Interval Between Two Cycles

时间窗: 3 months

MInimise The Grade Of Pain

时间窗: 3 months

To Normalise The Amount Of Blood Loss

时间窗: 3 months

次要结局

  • Ultrasonography of lower abdomen to be within normal limit(TSH T3 T4)

研究者

发起方
DR ANUDEEPA NATH
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验